Invention Grant
- Patent Title: Poxviral vaccines
-
Application No.: US15461978Application Date: 2017-03-17
-
Publication No.: US10576143B2Publication Date: 2020-03-03
- Inventor: Stefano Colloca , Riccardo Cortese , Antonella Folgori , Alfredo Nicosia
- Applicant: GLAXOSMITHKLINE BIOLOGICALS, SA
- Applicant Address: BE Rixensart
- Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee Address: BE Rixensart
- Agent Lisa Matovcik
- Priority: WOPCT/EP2013/055409 20130315
- Main IPC: A61K39/295
- IPC: A61K39/295 ; C12N7/00 ; A61K39/29 ; C12N15/86 ; A61K39/12 ; A61K39/00
Abstract:
The present application relates to novel administration regimens for poxviral vectors comprising nucleic acid constructs encoding antigenic proteins and invariant chains. In particular the use of said poxviral vectors for priming or for boosting an immune response is disclosed.
Public/Granted literature
- US20170333550A1 POXVIRAL VACCINES Public/Granted day:2017-11-23
Information query
